Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia
Clinical trial NCT00006040 · COMPLETED
Trial details
- NCT number
- NCT00006040
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-04-01
- Primary completion
- 2003-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.